Medication info

Helpobin Injection (L-Aspartate-L-Ornithine)

Prescription medicationInjectionsApproval withdrawn
Ingredient · strength
L-Ornithine-L-Aspartate›500mg / 1mL
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
A clear liquid that is colorless to pale yellow contained in a brown ampoule injection.
Packaging
For domestic use: 10 mL/ampoule X 10, for export: 5 mL/ampoule X 10, 10 mL/ampoule X 10
Approval status
Approval withdrawn

MFDS item code 199201504 · Notified 1992.11.04

This product's status changed to Approval withdrawn on 2024.02.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of hepatic encephalopathy in severe liver disease, including precoma and coma
Who uses it
Adults
Adult dosage
* 500 mg/mL, 5 g/10 mL For hepatic encephalopathy (including precoma and coma), up to 40 g (8 ampoules) per day of L-aspartic acid-L-ornithine may be mixed with an appropriate infusion solution and administered by intravenous infusion. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hepatic encephalopathy in severe liver disease, including precoma and coma

  • Severe liver disease
  • hepatic encephalopathy
  • pre-coma
  • coma
View approved original text

This medicine is used for patients with hepatic encephalopathy due to severe liver disease, from pre-coma stages to coma. In cases of severe liver dysfunction, toxins in the body may not be properly detoxified, leading to decreased brain function. This medication helps manage and improve the symptoms of severe hepatic encephalopathy. It effectively supports liver function, stabilizing the patient's condition and alleviating symptoms.

Dosage and Administration

Adult dosage

* 500 mg/mL, 5 g/10 mL For hepatic encephalopathy (including precoma and coma), up to 40 g (8 ampoules) per day of L-aspartic acid-L-ornithine may be mixed with an appropriate infusion solution and administered by intravenous infusion. Adjust the dose appropriately according to symptoms.

Precautions

This medication is provided as an ampoule injection and must be cut very carefully to avoid glass fragments being mixed in. Extra caution is needed when administering it to children or the elderly. This medication should not be administered to patients with certain conditions, such as those with lactic acidosis, methanol poisoning, fructose-sorbitol intolerance, fructose-1,6-diphosphatase deficiency, and severe renal impairment. Additionally, this drug contains potassium pyrosulfite, which may cause allergic reactions or asthma attacks in individuals allergic to sulfites, so it should be administered with caution. In some patients, these allergic reactions could be life-threatening, especially for those with asthma. Neurogenic symptoms such as a feeling of warmth in the occipital region or nausea may occur upon administration, and gastrointestinal discomfort or vomiting may also arise. If administered in high doses, blood and urine urea levels should be monitored to assess the condition. For patients with weak liver function, adjusting the infusion rate is important to reduce discomfort or vomiting symptoms. This drug should be administered slowly by intravenous infusion; rapid administration may cause side effects. Store this medication in a sealed container that is out of reach of children, and do not transfer it to another container; always store it in its original container tightly closed.

Side effects

  • Heat sensation in the occiput
  • nausea
  • discomfort in the stomach
  • vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This product should be stored in a sealed container to prevent air or moisture from entering. Additionally, it is advisable to store it in a location that avoids direct sunlight and at normal room temperature, that is, not too hot or too cold.

Appearance and packaging

Appearance

A clear liquid that is colorless to pale yellow contained in a brown ampoule injection.

Package unit

For domestic use: 10 mL/ampoule X 10, for export: 5 mL/ampoule X 10, 10 mL/ampoule X 10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.